Wave Life Sciences Ltd. — Director's Dealing 2016

Dec 10, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Wave Life Sciences Ltd. (WVE)
CIK: 0001631574
Period of Report: 2016-12-07

Reporting Person: GUERCIOLINI ROBERTO (See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-12-07	Ordinary Shares	M	20000	$2.47	Acquired	20000	Direct
2016-12-07	Ordinary Shares	M	4000	$2.47	Acquired	4000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-12-07	Share Option (Right to Buy)	$2.47	M	20000	Disposed	2025-03-22	Ordinary Shares (20000)	Direct
2016-12-07	Share Option (Right to Buy)	$2.47	M	4000	Disposed	2025-03-22	Ordinary Shares (4000)	Direct

Footnotes

F1: The incentive share option represented a right to purchase a total of 108,617 ordinary shares, 25% of which became exercisable on March 10, 2016, which was the first anniversary on which the option was granted, and the remaining shares vest in 36 equal monthly installments thereafter.

F2: The non-qualified option represented a right to purchase a total of 12,629 ordinary shares, 25% of which became exercisable on March 10, 2016, which was the first anniversary on which the option was granted, and the remaining shares vest in 36 equal monthly installments thereafter.